Diffuse large B-cell lymphoma classification tied up nicely with a "String"

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Molecular classification of diffuse large B-cell lymphoma (DLBCL) is a critical biologic, prognostic, and predictive distinction. Since the discovery of two molecular types of DLBCL in otherwise morphologically indistinguishable cases, numerous methodologies for making this distinction have been published. A method and technical platform may now be reaching consensus.

Original languageEnglish (US)
Pages (from-to)2204-2206
Number of pages3
JournalClinical Cancer Research
Volume21
Issue number10
DOIs
StatePublished - May 15 2015

Fingerprint

Lymphoma, Large B-Cell, Diffuse

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Diffuse large B-cell lymphoma classification tied up nicely with a "String". / Rimsza, Lisa M.

In: Clinical Cancer Research, Vol. 21, No. 10, 15.05.2015, p. 2204-2206.

Research output: Contribution to journalArticle

@article{111955169c6c47fc8070c0f6b13a2557,
title = "Diffuse large B-cell lymphoma classification tied up nicely with a {"}String{"}",
abstract = "Molecular classification of diffuse large B-cell lymphoma (DLBCL) is a critical biologic, prognostic, and predictive distinction. Since the discovery of two molecular types of DLBCL in otherwise morphologically indistinguishable cases, numerous methodologies for making this distinction have been published. A method and technical platform may now be reaching consensus.",
author = "Rimsza, {Lisa M}",
year = "2015",
month = "5",
day = "15",
doi = "10.1158/1078-0432.CCR-15-0253",
language = "English (US)",
volume = "21",
pages = "2204--2206",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Diffuse large B-cell lymphoma classification tied up nicely with a "String"

AU - Rimsza, Lisa M

PY - 2015/5/15

Y1 - 2015/5/15

N2 - Molecular classification of diffuse large B-cell lymphoma (DLBCL) is a critical biologic, prognostic, and predictive distinction. Since the discovery of two molecular types of DLBCL in otherwise morphologically indistinguishable cases, numerous methodologies for making this distinction have been published. A method and technical platform may now be reaching consensus.

AB - Molecular classification of diffuse large B-cell lymphoma (DLBCL) is a critical biologic, prognostic, and predictive distinction. Since the discovery of two molecular types of DLBCL in otherwise morphologically indistinguishable cases, numerous methodologies for making this distinction have been published. A method and technical platform may now be reaching consensus.

UR - http://www.scopus.com/inward/record.url?scp=84941979043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941979043&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-15-0253

DO - 10.1158/1078-0432.CCR-15-0253

M3 - Article

VL - 21

SP - 2204

EP - 2206

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 10

ER -